| Size | Price | Stock | Qty |
|---|---|---|---|
| 500mg |
|
||
| Other Sizes |
| Targets |
4-(Chloromethyl)-7-hydroxycoumarin does not have a specific pharmacological target as it is primarily used as a research chemical. Its function is to serve as a hydroxycoumarin derivative with antioxidant properties. The compound exhibits potent antioxidant effects and high hydroxyl radical-scavenging properties. Its mechanism of action involves scavenging free radicals and protecting cells from oxidative damage. The compound's antioxidant activity makes it a valuable tool for studying oxidative stress and related diseases.
|
|---|---|
| ln Vitro |
In vitro, 4-(Chloromethyl)-7-hydroxycoumarin has demonstrated potent antioxidant effects and high hydroxyl radical-scavenging properties. The compound's antioxidant activity can be measured using various in vitro assays such as DPPH radical scavenging, ABTS radical scavenging, and hydroxyl radical scavenging assays. The compound's ability to protect cells from oxidative damage can be studied in cell-based models of oxidative stress. Its antioxidant properties make it a valuable tool for research on oxidative stress-related diseases.
|
| ln Vivo |
Specific in vivo activity data for 4-(Chloromethyl)-7-hydroxycoumarin are not detailed in the available literature. As a research chemical with antioxidant properties, it may have potential therapeutic applications in diseases associated with oxidative stress. Its in vivo effects would be mediated through its antioxidant activity. Further studies in animal models are needed to confirm its in vivo efficacy and safety. The compound is currently in the research phase.
|
| Enzyme Assay |
In vitro antioxidant assays for 4-(Chloromethyl)-7-hydroxycoumarin typically involve measuring its ability to scavenge free radicals. For DPPH radical scavenging assay, the compound is incubated with DPPH radical solution, and the decrease in absorbance at 517 nm is measured. For hydroxyl radical scavenging assay, the compound is incubated with a hydroxyl radical-generating system, and the scavenging activity is measured. The compound is typically dissolved in DMSO or methanol for stock solutions and diluted in assay buffers. The IC50 value, representing the concentration required to scavenge 50% of the radicals, is calculated from the dose-response curve.
|
| Cell Assay |
In vitro cell-based assays using 4-(Chloromethyl)-7-hydroxycoumarin are performed to study its antioxidant and cytoprotective effects. Cells are treated with the compound at concentrations of 1-100 µM for 24-48 hours. Oxidative stress is induced using agents such as hydrogen peroxide or tert-butyl hydroperoxide. Cell viability is assessed using MTT or other cell viability assays. ROS levels are measured using fluorescent probes such as DCFH-DA. The compound's ability to protect cells from oxidative damage is assessed by measuring cell viability and ROS levels. The compound is typically dissolved in DMSO and diluted in cell culture medium.
|
| Animal Protocol |
Specific in vivo animal experiment protocols for 4-(Chloromethyl)-7-hydroxycoumarin are not detailed in the available literature. As a potential antioxidant agent, it could be tested in animal models of oxidative stress-related diseases. The compound could be administered orally or intraperitoneally. Oxidative stress markers would be measured in tissues and serum to assess the compound's antioxidant effects. The route of administration and dosing would depend on the specific experimental design.
|
| ADME/Pharmacokinetics |
Metabolism / Metabolites
4-(chloromethyl)-7-hydroxychromene-2-one is a known human metabolite of 2h-1-benzopyran-2-one 4-(chloromethyl)-7-ethoxy-. 4-(Chloromethyl)-7-hydroxycoumarin has a molecular weight of 210.61 g/mol and the formula C10H7ClO3. The compound appears as a white to light yellow to light orange powder to crystal. For storage, the compound is kept under refrigeration (0-10°C). Its purity is typically ≥98%. The compound is a hydroxycoumarin derivative with potent antioxidant effect and high hydroxyl radical-scavenging property. It contains a methyl group and a chlorine group in the heterocyclic ring. The compound is also known as CellHunt Blue CMHC. |
| Toxicity/Toxicokinetics |
Specific toxicological data for 4-(Chloromethyl)-7-hydroxycoumarin are not provided in the available sources. As a research chemical, it is intended for laboratory use only and is not for human consumption. Standard laboratory safety precautions should be followed when handling this compound, including the use of gloves and eye protection. The compound may cause irritation to skin, eyes, and respiratory tract upon contact.
|
| References |
|
| Additional Infomation |
4-(Chloromethyl)-7-hydroxycoumarin (CAS 25392-41-0) is a hydroxycoumarin derivative with potent antioxidant effect and high hydroxyl radical-scavenging property. It has the molecular formula C10H7ClO3 and a molecular weight of 210.61 g/mol. The compound appears as a white to light yellow to light orange powder to crystal. It is stored under refrigeration (0-10°C). 4-(Chloromethyl)-7-hydroxycoumarin contains a methyl group and a chlorine group in the heterocyclic ring. The compound is also known as CellHunt Blue CMHC. It is intended for research use only.
|
| Molecular Formula |
C10H7CLO3
|
|---|---|
| Molecular Weight |
210.6138
|
| Exact Mass |
210.008
|
| CAS # |
25392-41-0
|
| PubChem CID |
5398846
|
| Appearance |
Typically exists as solid at room temperature
|
| Density |
1.4±0.1 g/cm3
|
| Boiling Point |
409.6±45.0 °C at 760 mmHg
|
| Melting Point |
180-183ºC
|
| Flash Point |
201.5±28.7 °C
|
| Vapour Pressure |
0.0±1.0 mmHg at 25°C
|
| Index of Refraction |
1.619
|
| LogP |
2.38
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
1
|
| Heavy Atom Count |
14
|
| Complexity |
275
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
ClC([H])([H])C1=C([H])C(=O)OC2C([H])=C(C([H])=C([H])C1=2)O[H]
|
| InChi Key |
TXSLBPGPBNGHRW-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C10H7ClO3/c11-5-6-3-10(13)14-9-4-7(12)1-2-8(6)9/h1-4,12H,5H2
|
| Chemical Name |
4-(chloromethyl)-7-hydroxychromen-2-one
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 4.7481 mL | 23.7406 mL | 47.4811 mL | |
| 5 mM | 0.9496 mL | 4.7481 mL | 9.4962 mL | |
| 10 mM | 0.4748 mL | 2.3741 mL | 4.7481 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
